Skip to content

Author

F. Garbicz

We have 2 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Chemoimmunotherapy‐associated CD20 (MS4A1) resistance mutations in Waldenström macroglobulinemia: Epitope disruption independent of expression with implications for CD20‐directed cellular therapies

CD20, encoded by MS4A1 , is one of the earliest and most extensively used immunotherapeutic targets in B ‐ cell malignancies and the mechanisms underlying resistance remain poorly understood.

A. Guijosa, N. Tsakmaklis, S. Dhe-Paganon et al. · 0 citations
Open access Aug 2026

EP1137 - ECE_2413 - The importance of cell adhesion molecules CADM2/3 and miR-127 and miR432 for clinically non-functioning pituitary tumours

Novel genes and miRs are revealed in NF-PitNETs suggesting their potential regulatory role in cell adhesion, migration, and apoptosis therefore potentially contributing to their pathogenesis.

B. Rak-Makowska, S. Barry, M. Maksymowicz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.